While not statistically significant ( p > 0.05, based on Cox proportional hazard modeling), we saw a clear trend toward improved overall survival among individuals with renal cell carcinoma and a high TMB (Fig. 6 a).
← all excerpts
Burden of tumor mutations, neoepitopes, and other variants are weak predictors of cancer immunotherapy response and overall survival.
1
—
—